tiprankstipranks
Trending News
More News >
National Health Investors (NHI)
NYSE:NHI
US Market
Advertisement

National Health Investors (NHI) Ratios

Compare
692 Followers

National Health Investors Ratios

NHI's free cash flow for Q1 2025 was $0.97. For the 2025 fiscal year, NHI's free cash flow was decreased by $ and operating cash flow was $0.53. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.97 2.37 5.43 7.20 4.99
Quick Ratio
0.97 2.37 5.43 7.20 0.03
Cash Ratio
0.26 0.15 0.28 0.53 0.49
Solvency Ratio
0.16 0.17 0.13 0.17 0.15
Operating Cash Flow Ratio
0.41 1.24 2.65 3.00 2.65
Short-Term Operating Cash Flow Coverage
0.48 2.45 0.45 0.00 0.51
Net Current Asset Value
$ -831.88M$ -862.10M$ -837.70M$ -816.65M$ -1.16B
Leverage Ratios
Debt-to-Assets Ratio
0.45 0.46 0.46 0.44 0.48
Debt-to-Equity Ratio
0.89 0.91 0.90 0.83 1.00
Debt-to-Capital Ratio
0.47 0.48 0.47 0.45 0.50
Long-Term Debt-to-Capital Ratio
0.36 0.46 0.37 0.45 0.41
Financial Leverage Ratio
1.95 1.98 1.97 1.88 2.06
Debt Service Coverage Ratio
0.53 1.99 0.24 3.21 0.50
Interest Coverage Ratio
3.36 3.22 1.81 2.60 4.18
Debt to Market Cap
0.38 0.47 0.49 0.48 0.48
Interest Debt Per Share
28.84 27.44 26.63 28.49 34.96
Net Debt to EBITDA
4.20 4.28 7.42 5.70 4.83
Profitability Margins
Gross Profit Margin
96.70%96.40%96.48%96.10%97.10%
EBIT Margin
56.91%59.40%38.77%53.61%70.56%
EBITDA Margin
78.22%81.27%54.64%71.30%91.33%
Operating Profit Margin
54.37%55.90%29.16%44.25%66.34%
Pretax Profit Margin
40.75%42.02%23.55%37.48%55.68%
Net Profit Margin
41.17%42.41%8.29%20.82%40.67%
Continuous Operations Profit Margin
40.76%42.02%23.55%37.48%55.68%
Net Income Per EBT
101.04%100.95%35.21%55.54%73.05%
EBT Per EBIT
74.95%75.16%80.75%84.70%83.93%
Return on Assets (ROA)
5.07%5.45%0.92%2.19%4.34%
Return on Equity (ROE)
10.72%10.82%1.82%4.13%8.95%
Return on Capital Employed (ROCE)
8.25%7.64%3.33%4.77%7.28%
Return on Invested Capital (ROIC)
6.89%7.47%1.00%2.65%4.62%
Return on Tangible Assets
5.07%5.45%0.46%1.10%2.17%
Earnings Yield
4.38%5.60%0.99%2.37%4.38%
Efficiency Ratios
Receivables Turnover
0.95 0.97 3.40 3.00 3.39
Payables Turnover
0.39 0.34 0.39 0.64 0.54
Inventory Turnover
0.00 0.00 0.00 11.64M 0.02
Fixed Asset Turnover
0.00 0.00 0.13 0.13 0.12
Asset Turnover
0.12 0.13 0.11 0.11 0.11
Working Capital Turnover Ratio
-20.45 1.25 0.75 0.76 0.92
Cash Conversion Cycle
-555.84 -710.97 -833.14 -448.74 15.85K
Days of Sales Outstanding
385.41 376.58 107.40 121.47 107.80
Days of Inventory Outstanding
0.00 0.00 0.00 <0.01 16.43K
Days of Payables Outstanding
941.25 1.09K 940.54 570.21 682.13
Operating Cycle
385.41 376.58 107.40 121.47 16.54K
Cash Flow Ratios
Operating Cash Flow Per Share
4.67 4.25 4.14 4.61 5.19
Free Cash Flow Per Share
4.58 4.16 4.04 4.61 4.88
CapEx Per Share
0.07 0.09 0.10 <0.01 0.31
Free Cash Flow to Operating Cash Flow
0.98 0.98 0.98 1.00 0.94
Dividend Paid and CapEx Coverage Ratio
1.32 1.15 1.11 1.15 1.11
Capital Expenditure Coverage Ratio
63.03 49.28 40.04 3.29K 16.76
Operating Cash Flow Coverage Ratio
0.17 0.16 0.16 0.17 0.15
Operating Cash Flow to Sales Ratio
0.62 0.58 0.67 0.71 0.70
Free Cash Flow Yield
6.36%7.46%7.73%8.02%7.06%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
23.02 17.86 101.39 42.25 22.84
Price-to-Sales (P/S) Ratio
9.68 7.58 8.40 8.79 9.29
Price-to-Book (P/B) Ratio
2.28 1.93 1.84 1.74 2.04
Price-to-Free Cash Flow (P/FCF) Ratio
15.85 13.41 12.94 12.46 14.16
Price-to-Operating Cash Flow Ratio
15.23 13.14 12.62 12.46 13.32
Price-to-Earnings Growth (PEG) Ratio
18.07 0.04 -1.64 -0.77 0.87
Price-to-Fair Value
2.28 1.93 1.84 1.74 2.04
Enterprise Value Multiple
16.58 13.60 22.81 18.04 15.00
Enterprise Value
4.42B 3.54B 3.47B 3.84B 4.56B
EV to EBITDA
16.47 13.60 22.81 18.04 15.00
EV to Sales
12.89 11.06 12.46 12.86 13.70
EV to Free Cash Flow
21.11 19.57 19.18 18.22 20.88
EV to Operating Cash Flow
20.71 19.17 18.70 18.22 19.63
Tangible Book Value Per Share
31.60 29.36 28.81 33.18 34.07
Shareholders’ Equity Per Share
31.20 28.90 28.37 32.97 33.83
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.65 0.44 0.27
Revenue Per Share
7.50 7.37 6.21 6.53 7.45
Net Income Per Share
3.09 3.13 0.52 1.36 3.03
Tax Burden
1.01 1.01 0.35 0.56 0.73
Interest Burden
0.72 0.71 0.61 0.70 0.79
Research & Development to Revenue
0.00 0.00 <0.01 <0.01 <0.01
SG&A to Revenue
0.07 0.06 0.09 0.06 0.04
Stock-Based Compensation to Revenue
0.01 0.01 0.03 0.03 <0.01
Income Quality
1.53 1.37 2.83 1.88 1.25
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis